缺血核心低密度与取栓疗效的关联:SELECT2试验二次分析
该研究为SELECT2随机对照试验的探索性分析,纳入322例大核心梗死患者,评估严重CT低密度(≤26 HU)体积与血管内治疗疗效的关系。结果显示,严重低密度体积≥26 mL的患者取栓与药物治疗在mRS 0-3无显著关联,且与去骨瓣减压术相关;而<26 mL的患者取栓与mRS 0-3显著相关。
要点
- 严重CT低密度阈值定义为26 HU,中位CT密度为31 HU。
- 低密度体积≥26 mL者取栓与mRS 0-3无显著关联(aOR 0.98)。
- 低密度体积<26 mL者取栓与mRS 0-3显著相关(aOR 7.20)。
核心结论
- 大缺血区域内严重低密度可改变取栓疗效,并增加去骨瓣减压术的可能性,且独立于病灶体积。
研究设计与样本
- SELECT2随机对照试验的探索性分析,比较血管内治疗与药物治疗,纳入美国、加拿大、欧洲、澳大利亚和新西兰31个综合卒中中心的322例大核心梗死患者。
主要发现
- 在322例患者中,中位CT密度为31 HU(四分位距28-34),严重CT低密度阈值选定为26 HU。
- 缺血核心≤26 HU体积(每增加1 mL)与取栓后mRS 0-3的较低 odds 相关(aOR 0.96,95%CI 0.94-0.99),但与药物治疗无关(aOR 1.01,95%CI 0.98-1.03;交互作用P<0.01)。
- 在101例严重CT低密度≥26 mL的患者中,取栓与药物治疗相比,与mRS 0-3无显著关联(aOR 0.98,95%CI 0.33-2.88),且与去骨瓣减压术相关(≥26 mL组aOR 3.45,95%CI 1.09-10.86;<26 mL组aOR 0.74,95%CI 0.31-1.75;交互作用P=0.03)。
- 在221例严重低密度<26 mL的患者中,取栓与mRS 0-3相关(aOR 7.20,95%CI 3.55-15.47;交互作用P<0.01)。
关键数值与推荐
- 严重CT低密度阈值:26 HU(基于对侧丘脑灰质CT值下限99%CI)。
- 体积切点:≥26 mL与<26 mL。
- 主要结局:mRS 0-3;安全性结局:去骨瓣减压术。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We aimed to determine whether extensive severe computed tomography (CT) hypodensity, representing blood-brain barrier injury, would be associated with a reduced benefit of endovascular therapy (EVT) in patients presenting with large core stroke. METHODS: This study is an exploratory analysis of SELECT2 (Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke), a randomized controlled trial of EVT versus medical management in patients with large ischemic core who presented to 31 comprehensive stroke centers across the United States, Canada, Europe, Australia, and New Zealand. Visible CT hypodensity was outlined, and a threshold of severe CT hypodensity was defined as the lower 99% CI of contralateral thalamic gray matter in Hounsfield units (HU). The association between the volume of severe CT hypodensity and modified Rankin Scale (mRS) score of 0 to 3 was evaluated using logistic regression models, with adjustment for age, National Institutes of Health Stroke Scale, total noncontrast CT core volume, and a volume-by-treatment interaction. The relationship between severe CT hypodensity volume and the probability of an mRS score of 0 to 3 was used to select clinically relevant volume cut points for further evaluation. The treatment effect of EVT versus medical management on independent ambulation and hemicraniectomy was assessed in 2 subgroups based on these volume cut points. RESULTS: In 322 patients, the median CT density was 31 HU (interquartile range, 28-34). The selected threshold of severe CT hypodensity was 26 HU. The volume of ischemic core ≤26 HU (per 1 mL increase) was associated with lower odds of mRS score of 0 to 3 after EVT (adjusted odds ratio [aOR], 0.96 [95% CI, 0.94-0.99]), but not medical management (aOR, 1.01 [95% CI, 0.98-1.03]; Pinteraction<0.01). In 101 patients with ≥26 mL of severe CT hypodensity, EVT, compared with medical management, was not associated with mRS score of 0 to 3 (aOR, 0.98 [95% CI, 0.33-2.88]) and was associated with hemicraniectomy (≥26 mL: aOR, 3.45 [95% CI, 1.09-10.86] versus <26 mL: aOR, 0.74 [95% CI, 0.31-1.75]; Pinteraction=0.03), whereas among 221 patients with <26 mL of severe hypodensity EVT was associated with mRS score of 0 to 3 (aOR, 7.20 [95% CI, 3.55-15.47]; Pinteraction<0.01). CONCLUSIONS: Severe hypodensity within large ischemic regions modifies the thrombectomy treatment effect and increases the likelihood of hemicraniectomy, independent of lesion volume. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03876457.
引用
- Yogendrakumar V, Campbell BCV, Johns HT, et al. Association of Ischemic Core Hypodensity With Thrombectomy Treatment Effect in Large Core Stroke: A Secondary Analysis of the SELECT2 Randomized Controlled Trial. Stroke. 2025. PMID: 40151939. doi:10.1161/STROKEAHA.124.048899
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。